What Resflor Gold Treats: Main Uses and Benefits

The therapeutic use of this product is centered on a dual-action approach for conditions marked by increased physiological stress. The product is commonly used across conditions presenting with acute episodes.

The core domain is relevant for addressing Bovine Respiratory Disease (BRD) caused by specific bacterial pathogens, such as Mannheimia haemolytica and Pasteolus multocida. The product supports the management of the underlying infection while assisting with the management of the associated inflammatory state. It is applied when short-term symptomatic assistance is needed for symptoms related to systemic imbalance, including high body temperature (pyrexia) and inflammation.

The therapy is relevant in clinical settings marked by heightened systemic distress in specific patient groups, including beef cattle and non-lactating dairy cattle. This assists with maintaining functional stability and contributes to easing the overall symptom load during periods of heightened discomfort.

“The combination contributes to the overall therapeutic support by providing relief that helps patients cope more steadily with difficult episodes.”

---

Focus: Symptoms of High Body Temperature The formulation is commonly used to address the symptoms of high body temperature (fever) that frequently accompany acute respiratory infections in cattle.

Regulatory References

1. RESFLOR GOLD- florfenicol and flunixin meglumine injection - DailyMed

Who can and cannot use Resflor Gold?

The official eligibility criteria for Resflor Gold (florfenicol and flunixin meglumine) are strictly defined by regulatory authorities and limit its use to specific cattle populations based on age, production type, and underlying health.

Allowed Populations (As per Regulatory Labeling)

Population Type	Eligibility Status
Beef Cattle	Approved for use in Bovine Respiratory Disease (BRD).
Non-Lactating Dairy Cattle	Approved for use.

Populations Who Must Not Use (Contraindications)

Population Type	Restriction Status
Calves for Veal Processing	Absolutely Contraindicated.
Female Dairy Cattle 20 Months or Older	Not approved.
Animals Intended for Breeding	Not approved; safety is not established.
Cattle Less Than 2 Months of Age	Not approved.

Condition-Based Eligibility Restrictions

The product is strictly contraindicated in animals suffering from hepatic (liver), renal (kidney), or cardiac diseases. Use should also be avoided in cattle that are dehydrated, hypovolaemic, or hypotensive due to an increased risk of organ toxicity. Additionally, the medicine is contraindicated in animals with known hypersensitivity to either active ingredient or those at risk of gastrointestinal bleeding.

Interactions with other medicines and products

Official regulatory documents define specific restrictions for co-administering this product due to its active components, the antibiotic florfenicol and the Non-Steroidal Anti-Inflammatory Drug (NSAID) flunixin meglumine.

Interacting Product Category	Regulatory Constraint	Mechanism/Basis
Other NSAIDs and Glucocorticosteroids (Corticosteroids)	Must Not Be Administered Concomitantly	Increased risk of additional or exacerbated adverse effects, particularly gastrointestinal ulceration.
Other Anti-inflammatory Substances	Treatment-Free Period Required	A treatment-free period of at least 24 hours must be observed before starting this product to avoid increased adverse effects, considering the previous drug's properties.
Potentially Nephrotoxic Drugs	Avoid or Closely Monitor	Concurrent administration should be avoided due to the potential risk of increased renal toxicity, a known class effect of NSAIDs.
Highly Protein-Bound Substances	Caution/Toxic Effect Risk	The flunixin component is highly protein-bound; co-administration with other highly protein-bound drugs may lead to competition for binding sites, potentially resulting in toxic effects.
Other Veterinary Medicinal Products	Do Not Mix	The product must not be mixed with other veterinary medicinal products in the absence of documented compatibility studies (Major Incompatibilities).

How Resflor Gold Works

Resflor Gold's action is achieved through the independent, parallel actions of its two active ingredients on two separate biological targets: microbial ribosomes and host cyclooxygenase enzymes.

Targeting Bacterial Protein Synthesis

Florfenicol acts on the bacterial 70S ribosome. By binding to the 50S ribosomal subunit, it inhibits the peptidyl transferase enzyme, blocking the crucial step of protein elongation. This targeted interference with the bacteria's synthesis machinery results in the physiological control of pathogen replication, a mechanism that functionally limits bacterial proliferation within the host system.

Action within the Eicosanoid Cascade

Flunixin meglumine acts as an inhibitor of Cyclooxygenase (COX) enzymes, predominantly COX-2. This action directly suppresses the synthesis of Prostaglandin E2 ( PGE2), which mediates the pathological elevation of the thermoregulatory set point and peripheral nociceptive signaling. This enzyme inhibition results in the physiological attenuation of the febrile state by shifting the thermoregulatory set point and decreasing peripheral afferent signal transmission.

Dual Mechanistic Coordination

The mechanisms of Florfenicol and Flunixin are complementary: one targets microbial processes, while the other targets host enzyme activity. This parallel intervention supports a unified physiological outcome by addressing both the microbial challenge and the associated host inflammatory response.

How to Use Resflor Gold: Official Administration Guidelines

The usage of Resflor Gold is defined as a one-time, single-dose intervention for specific cattle populations. This combination product, containing florfenicol and flunixin meglumine, is administered exclusively by **subcutaneous injection.

---

Official Administration Protocol

The administration of the sterile solution adheres to the following procedural steps:

• Dose Calculation: The volume to be injected is based on the animal's exact body weight. The required dose rate is 40 mg florfenicol/kg and 2.2 mg flunixin/kg of body weight, which corresponds to 6 mL/100 lb of body weight, delivered in the single injection.
• Injection Site Constraint: The medication must be given only in the neck area of the animal.
• Volume Limit: To maintain proper administration constraints, the maximum volume administered at each injection site must not exceed 10 mL. If the calculated dose exceeds this volume, it must be split and delivered across multiple injection points in the neck.

---

Frequency and Population Rules

Resflor Gold is structured as a one-time treatment course, meaning subsequent doses are not part of the standard regimen. The instructions advise that if clinical signs persist approximately 72 hours after the single injection, the treatment protocol should be changed.

Administration Constraint	Detail
Frequency	Administered once (Single injection only).
Target Population	Beef cattle and non-lactating dairy cattle only.
Excluded Population	Not for use in female dairy cattle 20 months of age or older or in animals intended for breeding.

These instructions define the standardized approach to using the medicine, establishing the single, weight-calculated dose and specific procedural constraints for its correct delivery.

Research Exploring Bovine Respiratory Disease (BRD) and Associated Pyrexia

Resflor Gold was studied for its evaluation in conditions associated with Bovine Respiratory Disease (BRD), particularly when the condition is caused by specific bacteria and outcomes related to systemic imbalance, such as fever, were monitored. The primary research approach involved multiple Randomized Controlled Trials (RCTs). These studies were structured to evaluate the combination product against control groups that received either a saline injection or an antibiotic-only treatment, examining outcomes like the success rate of the treatment and the rapid measurement of Rectal Temperature. The evidence level for this core indication is graded as High.

Overview of Clinical Trial Designs and Long-Term Outcomes

The research scenarios included evaluation of the combination product against single-ingredient treatments and against other antimicrobial/NSAID combinations. Studies monitored the relationships between clinical success rates and re-treatment frequencies across these regimens. Follow-up phases were included in trials to track how long changes persisted, with extended observation periods often lasting up to 49 days to explore long-term performance outcomes, such as Mortality Rate and Body Weight Gain. Despite these efforts, long-term effects are not fully established.

Research in Specific Populations and Remaining Uncertainty

The main clinical trials were observed primarily in High-Risk Feedlot Calves and young cattle, although the licensed populations include Beef and Non-Lactating Dairy Cattle. Results apply only to the populations studied, meaning data for certain groups remain insufficient, and the ability to generalize some findings to all possible cattle types remains uncertain. Research highlights what is known, but data limitations exist, particularly in examining the combination product against the full scope of available treatments.

Key Studies & References RESFLOR GOLD- florfenicol and flunixin meglumine injection Label Information (DailyMed)

Common questions about Resflor Gold (FAQ)

Q: What is the main difference between Resflor Gold and other similar medicines?

A: Resflor Gold is classified in official documents as a fixed-dose combination product. This means it contains two active substances—an antibiotic (florfenicol) and a Non-Steroidal Anti-Inflammatory Drug or NSAID (flunixin meglumine)—delivered together in a single injection. This dual composition is intended to provide concurrent treatment for bacterial infection and control associated fever and inflammation.

Q: How long after taking Resflor Gold can a person start to feel a change?

A: According to the official protocol, Resflor Gold is a one-time, single-dose treatment. Regulatory instructions advise that if clinical signs persist approximately 72 hours after the injection, the treatment approach should be re-evaluated. This indicates that the medicine is expected to show its therapeutic effect within this timeframe.

Q: Is Resflor Gold used to treat common pain?

A: The official indication for Resflor Gold is strictly defined. It is used in conditions associated with Bovine Respiratory Disease (BRD) and specifically for the control of BRD-associated pyrexia (fever). The product is not approved for general or common pain management unrelated to its core indication.

Q: Does Resflor Gold cause tiredness or fatigue?

A: Official adverse reaction documentation lists specific effects observed, such as transient inappetence (decreased feed consumption), diarrhea, and injection site swelling. Tiredness or fatigue is not listed as an observed adverse reaction in the official safety profile for this product.

Q: Can Resflor Gold be taken if someone is already taking over-the-counter pain relievers?

A: The product contains an NSAID (flunixin meglumine). Official warnings describe that concomitant use with other anti-inflammatory drugs, including certain non-prescription pain relievers or other NSAIDs, is generally avoided or requires close monitoring. This is due to the potential risk of increased side effects, such as gastrointestinal disturbances.

Q: Can older adults use Resflor Gold safely?

A: Resflor Gold is a veterinary medicine intended for specific populations of cattle, not humans. The official restrictions based on age apply to the treated animals, specifically stating that the product is not approved for female dairy cattle 20 months of age or older or in calves under 3 months of age.

Q: Is Resflor Gold considered a strong medicine?

A: Official information indicates that this is a prescription-only veterinary medicine, meaning it requires the authorization of a licensed veterinarian. It is composed of two pharmacologically active agents, a synthetic antibiotic and a potent Non-Steroidal Anti-Inflammatory Drug (NSAID).

Q: How long does the effect of Resflor Gold usually last?

A: The drug is approved as a one-time, single-dose treatment. Follow-up research studies have tracked certain performance outcomes for up to 49 days. However, the acute therapeutic effectiveness is primarily assessed based on clinical response within 72 hours of administration.

Q: How quickly does the body process the components in Resflor Gold?

A: Pharmacological information notes that the flunixin component is known to be highly protein-bound. This is relevant to potential drug interactions, as caution is advised when co-administering it with other highly protein-bound drugs due to the potential for competition at binding sites.

Q: Does using Resflor Gold require any special monitoring or tests?

A: Official precautions emphasize that co-administration with other potentially nephrotoxic drugs (medicines that can harm the kidneys) should be carefully monitored. The use of this drug always requires the professional assessment and judgment of a licensed veterinarian.

Q: Can Resflor Gold be used by women who are pregnant or breastfeeding?

A: Resflor Gold is a veterinary product, and official documentation states that the effects of the product on bovine reproductive performance, pregnancy, and lactation have not been determined. Official warnings for NSAIDs in general note their potential to affect parturition (giving birth) and the estrous cycle.

Q: What kind of side effects are considered serious for Resflor Gold?

A: The safety profile includes contraindications (reasons the drug should not be used) that relate to potentially serious outcomes. The product is contraindicated in animals with severe pre-existing conditions, such as renal, hepatic, or cardiac dysfunction, due to an increased risk of organ toxicity. Hypersensitivity to the active ingredients is listed as a contraindication, and severe allergic reactions have been reported with other related formulations.

Q: Is it true that Resflor Gold is only used for very serious conditions?

A: The medicine is officially indicated for use in Bovine Respiratory Disease (BRD) when associated with specific bacteria. This is an acute infection that is a recognized health concern in cattle and requires veterinary intervention.

Q: What does 'contraindication' mean in the context of Resflor Gold?

A: A contraindication is a specific situation or condition where a drug should not be used because it could potentially cause harm or have detrimental effects. Official labeling for Resflor Gold lists several contraindications, such as use in breeding bulls or in animals with severe liver, kidney, or heart conditions.

Q: Are there known cases of people having severe allergic reactions to Resflor Gold?

A: The product is strictly marked as NOT FOR HUMAN USE. Official warnings state the product is Not for Human Use and advise against human exposure. The product is contraindicated in animals with a known hypersensitivity to the ingredients, and severe allergic reactions have been reported with a related florfenicol formulation in cattle.

Q: Can Resflor Gold be used for chronic conditions?

A: Official protocol defines Resflor Gold as a one-time, single-dose intervention for acute conditions associated with Bovine Respiratory Disease. If the animal's condition persists beyond 72 hours, the treatment protocol is required to be changed, suggesting it is not intended for chronic, long-term use.

Q: Are there specific patient groups where Resflor Gold studies showed less benefit?

A: Official regulatory documents indicate that the efficacy studies were conducted primarily in High-Risk Feedlot Calves. It is noted that the results apply only to the populations studied, and the ability to generalize findings to all possible cattle types remains uncertain, with long-term effects not fully established.

Q: Can young adults or teenagers use Resflor Gold?

A: Resflor Gold is strictly a veterinary medicine and is Not for Human Use. The official patient population is restricted to beef cattle and non-lactating dairy cattle. Age-related restrictions on use apply only to the treated animals, such as avoiding its use in female dairy cattle 20 months of age or older.

Q: Does Resflor Gold cause changes in appetite or weight?

A: Official adverse reaction documentation lists transient inappetence (decreased feed consumption) as an observed effect. Furthermore, Body Weight Gain is listed in the research evidence section as a performance outcome that was monitored during clinical trials.

Q: How does the mechanism of Resflor Gold differ from older treatments for similar conditions?

A: The unique feature of this product is the simultaneous delivery of an antibiotic (florfenicol) and an NSAID (flunixin meglumine) in a single subcutaneous injection. This provides a streamlined approach for both managing the infection and controlling the associated inflammation and fever concurrently.

Official Storage Requirements

Resflor Gold must be stored according to regulatory specifications to ensure stability. The product should be stored at temperatures not exceeding 30 C (86 F) and must not freeze. It is a mandatory requirement to KEEP OUT OF REACH OF CHILDREN.

Once the multi-dose vial is first entered, the solution is only stable for a defined in-use shelf-life and must be used within 28 days of first use. For the 500 mL vial, the official label limits access, stating do not puncture the stopper more than 20 times.

Disposal Instructions

Disposal instructions relate primarily to residue management in treated animals. The labeling requires a 38-day (or 46-day) withdrawal period; animals intended for human consumption must not be slaughtered within this period after the final treatment.